Skip to Main Content

Paper Details

Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade.
Sci Transl Med
33
2020
AKT, CD103, CD103+, CD103+ tumor-infiltrating dendritic cells, CD8, CD8+, CD8+ T cells, ICB, KDM5A, KDM5A gene signature, PD-1, PD-1), PI3K, S6K1, TLR, TLR7/8, Toll-like receptors 7 and 8, cancer, gene PTEN, histone 3 lysine 4 demethylase KDM5A, lysine, melanoma, mouse, multiple cancers, patients, phosphatase and tensin homolog, programmed cell death ligand 1, programmed cell death protein 1, tumor, tumor-associated M1 macrophages, tumors
Author NameAffiliation
Liangliang WangSchool of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University
Yan GaoSchool of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University
Yan GaoBeijing Obstetrics and Gynecology Hospital, Capital Medical University
Gao ZhangDuke University Medical Center
Dan LiSchool of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University
Zhenda WangSchool of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University
Jie ZhangCollege of Computing Sciences, New Jersey Institute of Technology
Leandro C HermidaCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Leandro C HermidaCenter for Bioinformatics and Computational Biology, University of Maryland, College Park
Leandro C HermidaCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Leandro C HermidaCenter for Bioinformatics and Computational Biology, University of Maryland, College Park
Lei HeSchool of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University
Zhisong WangSchool of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University
Jingwen SiSchool of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University
Shuang GengBeijing Advanced Innovation Center for Genomics (ICG), College of Chemistry, Peking-Tsinghua Center for Life Sciences, Peking University
Rizi Aiuniversity of california san diego
Rizi Aiuniversity of california san diego
Fei NingInstitute of Immunology and School of Medicine, Tsinghua University
Chaoran ChengCollege of Computing Sciences, New Jersey Institute of Technology
Haiteng DengTsinghua University
Dimiter S DimitrovUniversity of Pittsburgh
Yan SunLanzhou Institute of Husbandry and Pharmaceutical Science of CAAS
Yanyi HuangBeijing Advanced Innovation Center for Genomics (ICG), College of Chemistry, Peking-Tsinghua Center for Life Sciences, Peking University
Dong WangChengdu University of Traditional Chinese Medicine
Xiaoyu HuInstitute of Immunology and School of Medicine, Tsinghua University
Zhi WeiCollege of Computing Sciences, New Jersey Institute of Technology
Wei Wanguniversity of california san diego
Wei Wanguniversity of california san diego
Xuebin LiaoSchool of Pharmaceutical Sciences, Beijing Advanced Innovation Center for Human Brain Protection, Tsinghua University
  • 1 - 29

Datasets